On 2025-08-11, Serina Therapeutics, Inc. (SER) announced earnings per share of $-0.66 for the fiscal quarter ending 2025-06-30, missing the average analyst estimate of $-0.36.
The next expected annoucement date for quarterly earnings is 2025-11-11, with an average estimated earnings per share of $-0.40 for the fiscal quarter ending 2025-09-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-08-11 | 2025-06-30 | $-0.36 | $-0.66 |
| 2025-05-08 | 2025-03-31 | -- | $-0.49 |
| 2025-03-24 | 2024-12-31 | -- | $-0.27 |
| 2024-11-12 | 2024-09-30 | -- | $0.13 |
| 2024-08-09 | 2024-06-30 | -- | $0.51 |
| 2024-05-14 | 2024-03-31 | -- | $-3.38 |
| 2023-11-14 | 2023-09-30 | -- | $-4.93 |
| 2023-08-14 | 2023-06-30 | -- | $-2.46 |
| 2023-05-12 | 2023-03-31 | -- | $-3.17 |
| 2023-03-31 | 2022-12-31 | -- | $-2.46 |
| 2022-11-10 | 2022-09-30 | -- | $-2.11 |
| 2022-08-12 | 2022-06-30 | -- | $-2.46 |
| 2022-05-13 | 2022-03-31 | -- | $-2.46 |
| 2021-11-12 | 2021-09-30 | -- | $-1.76 |
| 2021-08-13 | 2021-06-30 | -- | $-2.46 |
| 2021-05-17 | 2021-03-31 | -- | $-1.76 |
| 2021-03-31 | 2020-12-31 | -- | $-2.46 |
| 2020-11-16 | 2020-09-30 | -- | $-2.46 |
| 2020-08-14 | 2020-06-30 | -- | $-2.46 |
| 2020-05-14 | 2020-03-31 | -- | $-2.82 |
| 2020-03-30 | 2019-12-31 | -- | $-2.82 |
| 2019-11-14 | 2019-09-30 | -- | $-3.17 |
| 2019-08-14 | 2019-06-30 | -- | $-2.82 |
| 2019-05-15 | 2019-03-31 | -- | $-3.17 |
| 2019-04-01 | 2018-12-31 | -- | $-3.17 |